AXA IM Alts
AXA IM Alts is a seed to growth stage investment firm. It has made 19 investments. Deal activity decreased year-over-year (1 deal in the last 12 months vs 5 prior). Average disclosed round size is $40.8M (across 20 rounds with reported amounts).
Portfolio
19
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Anne Bon
COO, Structured Finance & Impact Private Equity
Christophe Fritsch
Global Head of Alternative Credit
John O’Driscoll
Global Co-Head of Real Estate
Mark Gilligan
Head of Infrastructure
Pascal Christory
Global Head of Private Equity BNPP AM Alts & CEO BNPP AM Prime
Timothé Rauly
Global Co-Head of Real Estate
Fiona Choi Kurz
Managing Director
Rémi Lambert
Chief Investment Officer
Antoine Mesnage
Head of Australia
James Cox
Head of Funds Management (Australia)
Maxime Margery
Portfolio Manager, Listed Real Estate
Victoria Hall
Head of Funds, Infrastructure
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | — | Nov 2025 | |
| Series A | $8.5M | Jul 2025 | |
| CChloris | Series A | $8.5M | Jul 2025 |
| Series A | $8.5M | Jul 2025 | |
| Series A | $65M | May 2025 | |
| Series B | $57.5M | Apr 2025 | |
| IImbria | Series B | $57.5M | Jan 2025 |
| Series A | $30M | Jan 2025 | |
| Series B | $53M | Jan 2024 | |
| Growth | $18.5M | Jan 2024 | |
| LLimmaTech Biologics AG | Series A | $37M | Oct 2023 |
| Series B | $30M | Jun 2023 | |
| Seed | — | Mar 2023 | |
| LLimmaTech Biologics AG | Series A | $37M | Jan 2023 |
| EEyenuk | Series A | $26M | Oct 2022 |
| Growth | — | Oct 2022 | |
| Series C | $150M | May 2022 | |
| Seed | — | Jun 2018 | |
| Series C | $100M | Jan 2017 | |
| BBuen Manejo del Campo S.A. de CV | Series B | $15.6M | — |
| Series A | $26M | — | |
| Series B | $28M | — | |
| TThe Shared Wood Company | Growth | — | — |
| Seed | $2M | — | |
| Unknown | $58M | — |
Top Co-Investors
Last updated: 20 October 2026